# Kristen Fortney

> Kristen Fortney is a Series A investor at BioAge Labs backing Software and Biopharma. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [BioAge Labs](https://shizune.co/investors/profile/bioage-labs)
- Location: San Francisco, United States
- Total investments: 2
- Last investment: Dec 2024
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/kristenfortney

Kristen Fortney is a Series A investor at BioAge Labs in San Francisco focused on Software and Biopharma. Kristen Fortney is based out of United States and is the CEO & Co-Founder of BioAge Labs. Kristen Fortney attended the University of Toronto.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 1 | 50% |
| Biopharma | 1 | 50% |
| Health Care | 1 | 50% |
| Life Science | 1 | 50% |
| Therapeutics | 1 | 50% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 50% |
| Funding Round | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 1 | 50% |
| United Kingdom | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Bluenote Health | Bluenote Health operates as an AI platform for life sciences. | $10M |  | Dec 20, 2024 |  |
| Ochre Bio | Ochre Bio develops genomic medicines to rejuvenate donors' livers before transplant, so that everyone who needs a new liver gets one. They use genomics to find and shut down over-active genes driving disease and then go directly to testing therapies in discarded donor livers that keep alive outside of the body.Ochre Bio is within the heartof Oxford’s biotech innovation hub. Their scientific roots can be traced back to over 15 years leading liver genomics research and experience in bringing advanced therapies to market. | $30M | Series A | Oct 10, 2022 |  |

2 of 2 investments shown.

## Co-investors
- [BACKED VC](https://shizune.co/investors/profile/backed-vc) — VC Fund, 1 deal together
- [EIT Health](https://shizune.co/investors/profile/eit-health) — VC Fund, 1 deal together
- [Hermes-Epitek](https://shizune.co/investors/profile/hermes-epitek) — VC Fund, 1 deal together
- [Khosla Ventures](https://shizune.co/investors/profile/khosla-ventures) — VC Fund, 1 deal together
- [Lifeforce Capital](https://shizune.co/investors/profile/lifeforce-capital) — VC Fund, 1 deal together
- [LifeLink Ventures](https://shizune.co/investors/profile/lifelink-ventures) — VC Fund, 1 deal together

## About BioAge Labs

VC Fund · Richmond, United States

BIOAGE discovers and develops drugs to treat aging and associated diseases.

5 contacts available at BioAge Labs.

| Name | Title | Profile |
| --- | --- | --- |
| Dov Goldstein | Chief Financial Officer | https://shizune.co/investors/profile/dov-goldstein |
| Kristen Fortney | CEO & Co-Founder | https://shizune.co/investors/profile/kristen-fortney |
| Donald J. Santel | Independent Director | https://shizune.co/investors/profile/donald-j-santel |
| Eric Morgen | CMO / COO | https://shizune.co/investors/profile/eric-morgen |
| George Hartman | Consultant for Chemistry & Strategy | https://shizune.co/investors/profile/george-hartman |

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [Fuel Ventures](https://shizune.co/investors/profile/fuel-ventures-fund) — VC Fund
- [Business Growth Fund](https://shizune.co/investors/profile/business-growth-fund) — VC Fund

## Featured in investor lists
- [Biotech Angel Investors in United Kingdom](https://shizune.co/investors/biotech-angel-investors-united-kingdom)
- [Biotechnology Angel Investors in United Kingdom](https://shizune.co/investors/biotechnology-angel-investors-united-kingdom)

## FAQ

### What does Kristen Fortney invest in?

Kristen Fortney invests primarily in Software, Biopharma and Health Care startups, most often at Series A and Funding Round stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Kristen Fortney last invest?

The most recent investment recorded for Kristen Fortney closed in Dec 2024. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co